vimarsana.com

Latest Breaking News On - Institute of nuclear medicine - Page 16 : vimarsana.com

DRDO invites expression of interest for bulk production of Covid drug 2-DG

Read more about DRDO invites expression of interest for bulk production of Covid drug 2-DG on Business Standard. The 2-DG is developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of DRDO, in collaboration with Dr Reddy Laboratories.

Technical-assessment-committee
Technology-to
Institute-of-nuclear-medicine
Development-organisation
Defence-research
Nuclear-medicine
Allied-sciences
Indian-pharmaceutical
Active-pharmaceutical-ingredient
Drug-licensing
Come-first-served

DRDO invites EoI to transfer technology of COVID 2-DG drug for bulk production

DRDO invites EoI to transfer technology of 2-DG drug for bulk production | India News

India News: The Defence Research and Development Organisation (DRDO), which developed 2-Deoxy-D- Glucose (2-DG), a drug used for treatment of Covid-19 patients,

Hyderabad
Andhra-pradesh
India
Technical-assessment-committee
Institute-of-nuclear-medicine
Development-organisation
Defence-research
Nuclear-medicine
Allied-sciences
First-come-served-basis
Active-pharmaceutical-ingredient

View from India: 2-DG, India's first anti-Covid drug, coming to hospitals

View from India: 2-DG, India's first anti-Covid drug, coming to hospitals
theiet.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theiet.org Daily Mail and Mail on Sunday newspapers.

India
Hyderabad
Andhra-pradesh
Hungary
Russia
Brazil
Russian
Soviet
Bharat
Narendra-modi
National-institute-of-virology
Development-organization
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.